熱門資訊> 正文
Ionis，Recordati与Zilganerse签订了前美国许可协议
2026-06-25 16:06
- Ionis Pharmaceuticals (IONS) Wednesday reported that it has entered into a license agreement with Recordati, under which Recordati obtained exclusive rights to develop and commercialize zilganersen, an investigational RNA-targeted medicine for Alexander disease (AxD), in all countries outside the U.S.
- Ionis will maintain sole commercial responsibility for zilganersen in the U.S. and will continue to lead development globally.
- Recordati will be responsible for regulatory filings and commercialization outside the U.S., including country-specific support for early access pathways based on local regulations and access dynamics.
More on Ionis Pharmaceuticals
- Ionis Pharmaceuticals, Inc. (IONS) Presents at National Lipid Association (NLA) 2026 Scientific Sessions - Slideshow
- Ionis Pharmaceuticals, Inc. (IONS) Presents at Endocrine Society's Annual Meeting (ENDO 2026) - Slideshow
- Ionis Pharmaceuticals, Inc. (IONS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
- Ionis gains additional Tryngolza indication
- GSK, Ionis mark late-stage trial win for chronic hepatitis B therapy
推薦文章
打新攻略 | 太瘋狂了！16只新股「撞期」招股，物理AI、PCB等龍頭扎堆上陣，如何部署資金搏中「大肉籤」？
華盛早報 | AI硬件股集體「熄火」！閃迪、美光暴跌10%，韓股開盤即熔斷；蘋果醖釀採購中國存儲芯片
美股前瞻 | 美國6月「小非農」創3月來最低增幅！納指期貨盤前跌逾0.5%；美聯儲沃什今夜21點發布重要演講；存儲股走弱，閃迪跌超4%
華盛早報 | 芯片股漲瘋了！納指深夜再度飆漲1.5%；SK海力士啟動美股IPO，股票代碼「SKHY」
股價翻倍上漲，美光、英特爾和AMD第二季度市值合計增加約2萬億美元
美股前瞻 | 納指八成多頭被套！花旗稱拋壓遠未結束；海力士已提交在納斯達克上市申請；金價料創08年來最大月跌幅
「鏟子股中的鏟子股」行情爆了！半導體設備股正進入超級周期？一文讀懂該如何佈局
韓國狂砸5180億美元押注AI芯片，海力士赴美上市或再升30%？美銀、小摩齊高呼：本輪存儲超級周期將「更高、更長」！
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
